{
    "clinical_study": {
        "@rank": "63944", 
        "arm_group": [
            {
                "arm_group_label": "Group C", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Induction protocol: patients will be given 2 ml normal saline solution, 1 minutes later, 0.3 mg/kg etomidate is injected within 30 to 60 s, and 90 s after the injection of etomidate, 0.2 mg/kg midazolam, 3 \u03bcg/kg fentanyl, 0.6 mg/kg rocuronium are given sequently."
            }, 
            {
                "arm_group_label": "Group L1", 
                "arm_group_type": "Experimental", 
                "description": "Induction protocol: patients will be given 2 ml diluted lidocaine injection in which 20 mg lidocaine is contained, 1 minutes later, 0.3 mg/kg etomidate is injected within 30 to 60 s, and 90 s after the injection of etomidate, 0.2 mg/kg midazolam, 3 \u03bcg/kg fentanyl, 0.6 mg/kg rocuronium are given sequently."
            }, 
            {
                "arm_group_label": "Group L2", 
                "arm_group_type": "Experimental", 
                "description": "Induction protocol: patients will be given 2 ml diluted lidocaine injection in which 30 mg lidocaine is contained, 1 minutes later, 0.3 mg/kg etomidate is injected within 30 to 60 s, and 90 s after the injection of etomidate, 0.2 mg/kg midazolam, 3 \u03bcg/kg fentanyl, 0.6 mg/kg rocuronium are given sequently."
            }, 
            {
                "arm_group_label": "group L3", 
                "arm_group_type": "Experimental", 
                "description": "Induction protocol: patients will be given 2 ml lidocaine injection in which 40 mg lidocaine is contained, 1 minutes later, 0.3 mg/kg etomidate is injected within 30 to 60 s, and 90 s after the injection of etomidate, 0.2 mg/kg midazolam, 3 \u03bcg/kg fentanyl, 0.6 mg/kg rocuronium are given sequently."
            }
        ], 
        "brief_summary": {
            "textblock": "To evaluate the effect of pre-injection of lidocaine on myoclonus induced by induction with\n      etomidate during general anesthesia in elderly patients"
        }, 
        "brief_title": "Effect of Pre-injection of Lidocaine on Myoclonus Induced by Induction With Etomidate in Elderly Patients During General Anesthesia", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "General Anesthesia", 
        "condition_browse": {
            "mesh_term": "Myoclonus"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  1. Aged between 60 and 81 years 2. Body mass index:  20 to 30 kg/m2 3. American\n             Society of Anesthesiology (ASA) Physical Status: \u2160 or \u2161 4. Signed informed consent\n             form\n\n        Exclusion Criteria:\n\n          -  1. Use of sedatives or opioids 2. History of central nervous system diseases, like\n             epilepsy, shaking palsy, or chorea, etc 3. Hyperthyroidism 4. Serious diabetes 5.\n             Hyperkalemia 6. Cardiac surgery 7. Serious ventricular disease or atrioventricular\n             block 8. Liver or renal dysfunction 9. Allergies to amide local anesthetics or fat\n             emulsion"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "81 Years", 
            "minimum_age": "60 Years"
        }, 
        "enrollment": {
            "#text": "272", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 15, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02141737", 
            "org_study_id": "20140514"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Group L1", 
                    "Group L2", 
                    "group L3"
                ], 
                "description": "Lidocaine injection should be give before the injection of etomidate. In groups L1 and L2, 20 mg and 30 mg lidocaine injection will be diluted to 2ml separately.", 
                "intervention_name": "Lidocaine Hydrochloride Injection", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Group C", 
                    "Group L1", 
                    "Group L2", 
                    "group L3"
                ], 
                "description": "1 minute after the injection of lidocaine, 0.3 mg/kg etomidate will be given in 30 to 60 s.", 
                "intervention_name": "Etomidate Fat Emulsion Injection", 
                "intervention_type": "Drug", 
                "other_name": "Fu Er Li"
            }, 
            {
                "arm_group_label": [
                    "Group C", 
                    "Group L1", 
                    "Group L2"
                ], 
                "description": "2 ml normal saline will be given 1 minute before the injection of etomidate in patients in group C, and in group L1 and L2, normal saline is used to dilute lidocaine injection to 2 ml.", 
                "intervention_name": "normal saline", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Group C", 
                    "Group L1", 
                    "Group L2", 
                    "group L3"
                ], 
                "description": "0.02 mg/kg midazolam will be given to the patients in all groups 90 s after the injection of etomidate.", 
                "intervention_name": "Midazolam Injection", 
                "intervention_type": "Drug", 
                "other_name": "Li Yue Xi"
            }, 
            {
                "arm_group_label": [
                    "Group C", 
                    "Group L1", 
                    "Group L2", 
                    "group L3"
                ], 
                "description": "3 \u03bcg/kg fentanyl will be given to patients in all groups after the injection of midazolam.", 
                "intervention_name": "Fentanyl Citrate Injection", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Group C", 
                    "Group L1", 
                    "Group L2", 
                    "group L3"
                ], 
                "description": "0.6 mg/kg rocuronium will be given to patients in all groups after the injection of fentanyl.", 
                "intervention_name": "Rocuronium Injection", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Anesthetics", 
                "Midazolam", 
                "Etomidate", 
                "Fentanyl", 
                "Lidocaine", 
                "Rocuronium"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 16, 2014", 
        "location": {
            "contact": {
                "email": "guoyu986121@163.com", 
                "last_name": "Yu Guo", 
                "phone": "+86-18009200936"
            }, 
            "facility": {
                "address": {
                    "city": "Xi'an", 
                    "country": "China", 
                    "state": "Shanxi"
                }, 
                "name": "TangDu Hospital,FMMU"
            }, 
            "investigator": {
                "last_name": "Yu Guo", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "4", 
        "official_title": "Effect of Pre-injection of Lidocaine on Myoclonus Induced by Induction With Etomidate in Elderly Patients During General Anesthesia", 
        "overall_contact": {
            "email": "guoyu986121@163.com", 
            "last_name": "Yu Guo", 
            "phone": "+86-18009200936"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "myoclonic movements are graded as 0=no  myoclonus, 1=mild myoclonus (short movement of a body segment e.g., a finger or a wrist), 2=moderate myoclonus (mild movement of  two  different  muscle  groups  e.g.,  face  and  arm), or  3=severe myoclonus (intense myoclonic movement in two or more muscle groups, fast adduction of a limb)", 
                "measure": "severity of myoclonus induced by", 
                "safety_issue": "No", 
                "time_frame": "90 seconds from the beginning of etomidate injection"
            }, 
            {
                "description": "The intensity of pain was graded using a verbal rating scale. 0-None (negative response to questioning)\nMild pain (pain reported only in response to questioning without any behavioral signs)\nModerate pain (pain reported in response to questioning and accompanied by a behavioral sign or pain reported spontaneously without questioning)\nSevere pain (strong vocal response or response accompanied by facial grimacing, arm withdrawl or tears)", 
                "measure": "intensity of injection pain", 
                "safety_issue": "Yes", 
                "time_frame": "during the injection of etomidate, expected to be within 1 minutes"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02141737"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Heart rate and mean arterial pressure will be recorded before induction, before the injection of etomidate, 1 minute and 2 minutes after injection of etomidate", 
            "measure": "hemodynamic parameters after injection of etomidate", 
            "safety_issue": "Yes", 
            "time_frame": "baseline to 2 minutes after injetion of etomidate"
        }, 
        "source": "Tang-Du Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Tang-Du Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}